rs119103267

Variant summary

Our verdict is Pathogenic.
+13 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 13 classification points (ACMG Germline Pathogenicity v2019). PS3PM5PP2PP3_ModeratePP5_Strong

The NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000453 (AC=731) in the gnomAD database across 1,614,174 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.000546. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000803475: Well-established functional studies show a deleterious effect (PMID:26085578)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R707P: Likely_pathogenic (ClinVar VariationId 637750, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R707?: Uncertain_significance (ClinVar VariationId 917375, 1 star); p.R707Q: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1806999) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00047 ( 1 hom. )

Consequence

MFN2
NM_014874.4 missense

Scores

7
11
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:32O:2

Conservation

PhyloP100: 2.89

Publications

46 publications found
Variant links:
Genes affected
MFN2 (HGNC:16877): (mitofusin 2) This gene encodes a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. This protein is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke. Two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
MFN2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 2A2
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • neuropathy, hereditary motor and sensory, type 6A
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • multiple symmetric lipomatosis with partial lipodystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • hereditary motor and sensory neuropathy
    Inheritance: SD Classification: STRONG Submitted by: PanelApp Australia
  • hereditary motor and sensory neuropathy type 6
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • multiple symmetric lipomatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe early-onset axonal neuropathy due to MFN2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014874.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 13 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000803475: Well-established functional studies show a deleterious effect (PMID:26085578).; SCV000251722: Functional studies show that R707W alters gene product function and signaling (PMID: 30158064); SCV000966809: analysis of patient fibroblasts suggest that the p.Arg707Trp variant may impair mitochondrial function (Sawyer 2015).; SCV005088857: Functional studies using transfected fibroblasts have shown that the variant impairs MFN2-MFN2 protein interactions in mitochondria, making mitochondria prone to perinuclear aggregation. PMID:26085578; SCV005399281: "This variant has strong functional evidence supporting abnormal protein function. Patient fibroblasts homozygous for this variant demonstrated reduced capabilities to form MFN2 homo-oligomers leading to reduced mitochondrial fusion and mitochondria which were more prone to aggregation (PMID: 26085578)."; SCV000547929: Experimental studies have shown that this missense change affects MFN2 function (PMID: 26085578).; SCV000741959: Functional analysis in patient fibroblasts demonstrated that the p.R707W alteration impairs mitofusin 2 homodimer formation leading to mitochondrial aggregation (Sawyer, 2015).; SCV000914347: Functional studies in U2OS cells homozygous for the p.Arg707Trp variant demonstrate a reduced ability to form homotypic MFN2 protein interactions in vitro and to tubulate mitochondria which were more prone to aggregation (Sawyer et al. 2015).; SCV002500234: At least one publication reports experimental evidence evaluating an impact on protein function, showing that the variant protein resulted in mitochondrial aggregation and defects in homo-oligomerization (Sawyer_2015).; SCV004113565: Functional studies in fibroblasts show that the p.Arg707Trw variant impairs MFN2-MFN2 protein interactions in mitochondria, making mitochondria prone to perinuclear aggregation (Sawyer et al. 2015. PubMed ID: 26085578).; SCV003920211: In addition, a functional study in fibroblasts has shown a deleterious effect of this variant (Sawyer 2015 PMID:26085578).
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R707P: Likely_pathogenic (ClinVar VariationId 637750, 1 star); Other variants at the same amino acid residue (not pathogenic): p.R707?: Uncertain_significance (ClinVar VariationId 917375, 1 star); p.R707Q: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1806999)
PP2Missense in gene with low missense rate
Missense in gene constrained for missense variation where missense is common disease mechanism (PP2); Missense in a gene constrained for missense variation (gnomAD Z-score: 3.228). ClinVar shows strong pathogenic missense enrichment: 177 P/LP and 16 B/LB missense entries (ratio 11.1×).
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate).
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (32/32 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_014874.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFN2
NM_014874.4
MANE Select
c.2119C>Tp.Arg707Trp
missense
Exon 18 of 19NP_055689.1O95140-1
MFN2
NM_001127660.2
c.2119C>Tp.Arg707Trp
missense
Exon 17 of 18NP_001121132.1O95140-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFN2
ENST00000235329.10
TSL:1 MANE Select
c.2119C>Tp.Arg707Trp
missense
Exon 18 of 19ENSP00000235329.5O95140-1
MFN2
ENST00000675298.1
c.2119C>Tp.Arg707Trp
missense
Exon 18 of 19ENSP00000501839.1A0A6Q8PFJ4
MFN2
ENST00000675817.1
c.2251C>Tp.Arg751Trp
missense
Exon 19 of 20ENSP00000502422.1A0A6Q8PGV8

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000269
AC:41
Hom:0
AN:152168
Cov:33
GnomAD2 exomes
AF: 0.000251
AC:63
AN:251494
GnomAD4 exome
AF: 0.000472
AC:690
Hom:1
AN:1461888
Cov:31
GnomAD4 genome
AF: 0.000269
AC:41
Hom:0
AN:152286
Cov:33
TOPMed (Bravo)
AF: 0.000246
AC:65
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.000347
AC:174
Hom:0
AN:500896
Local & regional cohorts 6 sources
ABraOM SABE-WGS-1171
AF: 0.000427
AC:1
Hom:0
AN:2342
ESP6500 (Exome Variant Server)
AF: 0.000384
AC:5
AN:13006
Korea4K (4,157 Koreans)
AF: 0.000138
AC:1
AN:7234
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00
AC:0
Hom:0
AN:122370
Turkish Variome
AF: 0.000647
AC:1
Hom:0
AN:1546
UK10K
AF: 0.000397
AC:3
AN:7562
Showing 12 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.00108 *1211112 0.000908 *1617618
BipEx
(Bipolar disorder (including schizoaffective))
0.000563 1628420 0.000589 1728844
Epi25
(Epilepsy)
0.000358 1541958 0.000314 2166888
SCHEMA
(Schizophrenia)
0.000152 18118122 0.000227 42184806
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
8
-
-
not provided (8)
5
-
-
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; (5)
4
-
-
Charcot-Marie-Tooth disease type 2A2 (4)
3
-
-
MFN2-related disorder (3)
2
-
-
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;C4721887:Charcot-Marie-Tooth disease type 2A2;CN305336:Neuropathy, hereditary motor and sensory, type 6A (2)
1
-
-
Charcot-Marie-Tooth disease (1)
1
-
-
Charcot-Marie-Tooth disease type 2 (1)
1
-
-
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;C4721887:Charcot-Marie-Tooth disease type 2A2 (2)
1
-
-
Inborn genetic diseases (1)
1
-
-
Multiple symmetric lipomatosis (1)
1
-
-
Multiple symmetric lipomatosis;C4310725:Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; (1)
1
-
-
Neuropathy, hereditary motor and sensory, type 6A (1)
1
-
-
Peripheral axonal neuropathy (1)
1
-
-
Semidominant MFN2-related disorders (1)
1
-
-
Tip-toe gait (1)

Computational Scores

AlphaGenome AVI
Pathogenic24
AlphaMissense
Uncertain0.37
BayesDel_addAF
Pathogenic0.21D
BayesDel_noAF
Pathogenic0.41
CADD
Pathogenic29
DANN
Pathogenic1.0
DEOGEN2
Uncertain0.79D
Eigen
Uncertain0.48
Eigen_PC
Uncertain0.46
FATHMM_MKL
Uncertain0.90D
GPN-Star LLR
N/A-8.2
GPN-Star score
N/A8.2
LIST_S2
Uncertain0.96D
M_CAP
Uncertain0.19D
MetaRNN
Pathogenic0.84D
MetaSVM
Pathogenic1.0D
Mutation Taster
N/A22/78disease causing (ClinVar)
MutationAssessor
Benign1.4L
PhyloP100
Benign2.9
popEVE
Benign-3.5
PrimateAI
Uncertain0.66T
PROVEAN
Uncertain-2.8D
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Pathogenic0.84
Sift
Uncertain0.0050D
Sift4G
Uncertain0.013D
Varity_R
N/A0.60
VESM-3B
Benign-9.3
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.